Log In
BCIQ
Print this Print this
 

NUC-3373

  Manage Alerts
Collapse Summary General Information
Company NuCana BioMed Ltd.
DescriptionModified version of 5-fluorouracil (5-FU)/floxuridine using ProTide technology
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationSolid tumors
Indication DetailsTreat solid tumors
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today